Trials are meaningful for clinical decision making only when their endpoints are valid and comparable

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|5|1175-1177

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.5, 2015-05, pp. : 1175-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Making or Losing Money with Participation in Clinical Trials: A Decision Analysis

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 411-416

Karger

Access to resources Recommend Favorite

Which Endpoints to Use in Clinical Trials in Venous Thromboembolism?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 108-108

Karger

Access to resources Recommend Favorite

Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials?

By  

Nephron Clin Pract, Vol. 119, Iss. 3, 2011-08 ,pp. : c195-c199

Karger

Access to resources Recommend Favorite

Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain

By Silberstein S. D.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 861-867

Informa Healthcare

Access to resources Recommend Favorite

Testing for the Integrity of Blinding in Clinical Trials: How Valid Are Forced Choice Paradigms?

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 3, 2003-04 ,pp. : 128-131

Karger

Access to resources Recommend Favorite